Blood Podcast

podcast

Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of...

Science 397 recordings 2019 → today Weekly updated yesterday
Search in Blood Podcast →

All episodes

161–180 of 397
Fibrin polymerization and thrombosis; preventing CD19-negative relapse after CAR T-cell therapy in ALL; and impact of aberrant FUS condensates on HSC aging contributed by Lukas · Jan 11, 2024
CD24Fc for prevention of GVHD; origins of active EBV disease; the role of PF4 in platelet activation contributed by Lukas · Jan 4, 2024
Profiling a new VITT-like disorder; real-world outcomes of tafasitamab and lenalidomide in LBCL; and spatial mapping of human hematopoiesis contributed by Lukas · Dec 28, 2023
A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients contributed by Lukas · Dec 21, 2023
ETP and MRD for risk assessment in T-ALL; allogeneic HCT outcomes in CGD; effects of pathogenic/likely pathogenic variants in inherited hemostasis disorders contributed by Lukas · Dec 14, 2023
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML; inhibition of PLK4 in TP53-mutated AML; the role of CD44 in Plasmodium falciparum infection contributed by Lukas · Dec 7, 2023
High-risk cytogenetics in solitary bone plasmacytomas; complement activation in vaso-occlusive pain episodes; platelet reactivity to predict thrombotic disease risk contributed by Lukas · Nov 30, 2023
Very long-term follow-up of FCR therapy for CLL, risk assessment of KMT2A-rearranged B-cell precursor ALL in adults; anti-myeloma therapy using antibodies armed with B-BiTEs contributed by Lukas · Nov 23, 2023
Fractionated gemtuzumab ozagamicin Dosing in Elderly AML Patients; Loss-of-function of ENT3 drives histiocytosis; Alternative splicing of CD20 5’-UTR in B-lymphomas contributed by Lukas · Nov 16, 2023
Review Series on RNA Therapeutics in Hematology contributed by Lukas · Nov 14, 2023
Prognostic significance of splicing factor gene mutations in AML; therapy resistance in multiple myeloma; the effects of KIT ligand deletion on HSC homeostasis contributed by Lukas · Nov 9, 2023
Targeting prostacyclin to inhibit platelet activation; MRD-tailored myeloma maintenance; AREG and HSC function in DNA damage repair deficiency and aging contributed by Lukas · Nov 2, 2023
Lenalinomide plus rituximab for elderly patients with DLBCL, platelet GP6-mediated neutrophil recruitment in acute lung injury, and the role of AXL3 in mantle cell lymphoma. contributed by Lukas · Oct 26, 2023
Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma contributed by Lukas · Oct 19, 2023
IL-15 inhibitor BNZ-1 is safe and effective in T-cell LGLL, gene therapy trial for Wiskott-Aldrich syndrome, and ethical framework to select patients for CAR T-cell therapy contributed by Lukas · Oct 12, 2023
DDX41 gene variant prevalence and AML/MDS risk, VITAL mAb treatment of light chain amyloidosis, and movement/neurocognitive toxicities after BCMA CAR T cell treatment contributed by Lukas · Oct 5, 2023
IL-7 receptor signaling in B-cell differentiation, venetoclax plus obinutuzumab in older patients with CLL, LDL promotes microvascular thrombosis via von Willebrand Factor contributed by Lukas · Sep 28, 2023
Real-world CAR T therapy in older DLBCL patients, monoclonal antibody blocking APC for hemophilia therapy, and targeting the epichaperome in AML contributed by Lukas · Sep 21, 2023
Obinutuzumab, ibrutinib, and venetoclax in untreated CLL with deletion(17p)/TP53 mutation; NOTCH2 mutants promote chemo-resistance in DLBCL; and the role of DBY/HLA class II complexes in chronic GVHD contributed by Lukas · Sep 14, 2023
Long-term outcomes with pembrolizumab in Hodgkin lymphoma, the “incredible ULK” alleviates β-thalassemia, and recommendations for managing CAR T hematotoxicity contributed by Lukas · Sep 7, 2023
page 9 of 20 «« ← Prev Next → »»

Charts

module · podcast

🇰🇷 #20 · 🇲🇽 #27 · 🇧🇷 #31 · 🇿🇦 #35 · 🇦🇷 #41 · 🇮🇹 #53 · 🇯🇵 #71 · 🇮🇳 #76 · 🇨🇴 #112 · 🇨🇭 #125 · +18 more

charted in 29 countriesFull rankings →

Activity

module · podcast

5 episodes · last 30 days

Thu 52Tue 1Fri 1

Episodes per week over the last six months.

About

module · podcast

Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles. Subscribe and never miss a new episode.

American Society of Hematology Website RSS Apple